Nanosonics is a medical technology company with its flagship product being the trophon EPR system. The trophon system disinfects ultrasound probes with rapid efficiency. Ultrasound probes are vitally important to hospitals and medical clinics because they are the things that radiographers and doctors use to see what’s going on inside the patient’s body. Nanosonics claims to reduce error and increase efficiency — saving clinics time and making them money.
Forget CSL shares, Cochlear Ltd (ASX: COH), Nanosonics Ltd (ASX:NAN) and ResMed Inc (ASX:RMD) shares are amongst my top three ASX healthcare shares.
With many experts and investors worried about a recession and obsessing over an inverted yield curve, what can you invest in to protect your wealth during a downturn?
Nanosonics Ltd (ASX:NAN) and CSL Ltd (ASX:CSL) shares could keep beating the S&P/ASX 200 (INDEXASX:XJO) index.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 0.14% at lunch.
Nanosonics Ltd. (ASX:NAN) shares could rise after NAN released its half-year results with net profit up 221% to $7.1 million.
ASX small-cap shares are a great watering hole for sensible investors, in my opinion. Here’s why…
In this video, Strawman’s Andrew Page presents on his investing strategy and identifies one growing technology stock as part of Strawman and Rask’s Melbourne investor event.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 0.56% at lunch.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 0.13% at lunch.
